Hologen
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $150.0Mattributed |
|---|---|
| Latest round | series-a, $150.0M, 2026-01-01attributed |
| Founded | 2024 |
| Headquarters | London UK |
| Industry | bio |
| Stage | series-a |
| Website | hologen.ai |
Hologen is an AI biotech building Large Medicine Models that fuse clinical records, 3D imaging, genetics, and biology data to guide drug development. It partners with pharma on late-stage neurological and metabolic programs, including a $230M Parkinson's JV with MeiraGTx. Backed by Eric Schmidt to surface responders trials miss.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-01-01 | series-a | $150.0M | undisclosed |
Detected tech stack
Amazon CloudFront, Amazon S3, Amazon Web Services, Next.js, React
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $150.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $150.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | hologen.ai, read 2026-05-02 |
| Description | self-reported | hologen.ai, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.